StockData
Tango Therapeutics, Inc. logo

Tango Therapeutics, Inc. (TNGX) dividend history

TNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/30128% above fair value
$22.11−2.06 (-8.52%)

Close on Nov 17, 2026Market cap $3.73BP/E –Yield –

Dividends

Tango Therapeutics has not reported a dividend

No dividend per share appears in Tango Therapeutics's annual filings since fiscal 2019.

See a number that looks wrong?